Page last updated: 2024-08-17

propionamide and Neoplasms

propionamide has been researched along with Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gassner, C; Kniess, T; Laube, M; Pietzsch, J1
Dobs, AS; Zilbermint, MF1
Dumont, F; Foidart, JM; Frankenne, F; Lejeune, A; Oltenfreiter, R; Slegers, G; Staelens, L1

Reviews

1 review(s) available for propionamide and Neoplasms

ArticleYear
Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia.
    Future oncology (London, England), 2009, Volume: 5, Issue:8

    Topics: Amides; Anilides; Cachexia; Clinical Trials as Topic; Humans; Neoplasms; Receptors, Androgen

2009

Other Studies

2 other study(ies) available for propionamide and Neoplasms

ArticleYear
Synthesis and Cyclooxygenase Inhibition of Sulfonamide-Substituted (Dihydro)Pyrrolo[3,2,1-
    Molecules (Basel, Switzerland), 2019, Oct-22, Volume: 24, Issue:20

    Topics: Amides; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Design; Humans; Hydrophobic and Hydrophilic Interactions; Indoles; Neoplasms; Prodrugs; Structure-Activity Relationship; Sulfonamides

2019
New radioiodinated carboxylic and hydroxamic matrix metalloproteinase inhibitor tracers as potential tumor imaging agents.
    Nuclear medicine and biology, 2004, Volume: 31, Issue:4

    Topics: Amides; Animals; Biomarkers, Tumor; Feasibility Studies; Iodine Radioisotopes; Isotope Labeling; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Metabolic Clearance Rate; Mice; Neoplasms; Organ Specificity; Propionates; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution

2004